HLA-E and neoplasm: High expression of the inhibitory receptor NKG2A on tumor-infiltrating NK cells and its ligand human leukocyte antigen E (HLA-E) on the surface of tumor cells was correlated with reduced cytotoxicity and disease progression (Fig. 3) [130].